Financial Network Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.4K Buy
182
+4
+2% +$1.77K 0.09% 187
2026
Q1
$79.5K Buy
178
+79
+80% +$36.8K 0.08% 198
2025
Q4
$44.9K Buy
99
+13
+15% +$5.6K 0.05% 283
2025
Q3
$33.7K Buy
86
+29
+51% +$12.1K 0.04% 315
2025
Q2
$25.4K Buy
57
+7
+14% +$3.23K 0.03% 336
2025
Q1
$24.2K Buy
50
+15
+43% +$6.99K 0.03% 322
2024
Q4
$14.1K Sell
35
-8
-19% -$3.71K 0.03% 283
2024
Q3
$20K Buy
43
+9
+26% +$4.32K 0.02% 364
2024
Q2
$15.9K Buy
+34
New +$14.8K 0.01% 428

Other funds holding VRTX

Financial Network Wealth Advisors's VRTX Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $1.77K and bringing the position to 182 shares worth $90.4K. The position accounts for 0.09% of the portfolio, ranked #187.

Financial Network Wealth Advisors first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Financial Network Wealth Advisors held 182 shares of Vertex Pharmaceuticals worth $90.4K as of Q2 2026.
  • Financial Network Wealth Advisors bought 4 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.77K.
  • Vertex Pharmaceuticals made up 0.09% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #187 holding.
  • Financial Network Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.